ANALYSIS: From advising drug-makers how to “turbocharge” sales to working for corrupt governments, a new book lays bare how the consulting giant’s track record defies its much-touted “values”.
Global consulting firm McKinsey has long been considered the world’s most prestigious professional services outfit. But recently, it has also gained aFrom advising pharmaceutical companies on how to sell more Oxycontin to working for corrupt governments in South Africa, Russia and Malaysia, the firm has come under growing scrutiny from the public and state prosecutors alike in the past decade.
Purdue Pharma was another client, and its work for that Oxycontin developer included sales programs that promised to “turbocharge” sales and allegedly suggested targeting “high abuse-risk patients” and pitching to the doctors most likely to prescribe opioids in large volumes. This hypocrisy is more of an issue than the work itself, the authors say, and the reason why so many disillusioned former McKinsey staff were willing to go on the record for their book.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
NSW trial to allow prospective first home buyers to swap stamp duty for ongoing land taxBuyers will be able to choose a $400 annual fee and 0.3% of the land value while it’s their primary residence instead of stamp duty
Read more »
Power, politics and procrastination: Albanese’s taxing teaseThe government is not ready to make the argument on tax cuts because it’s not yet sure what the decision means.
Read more »
‘It’s not moral panic, it’s reality’: Todd Sampson documentary interrogates internet’s toxic influenceIn Mirror Mirror, the former advertising executive argues technology is an unregulated psychological experiment that is changing our brains
Read more »
Don’t stress! The HSC isn’t the only pathway to a fulfilling work lifeOpinion: The HSC is important, but for young people not yet sure of what they want to do beyond school, it’s not the be-all and end-all
Read more »
Value priced to outperform growth, says GMOGrantham’s GMO is beating the stock market correction by betting on value stocks and shorting growth.
Read more »